These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8195819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T, Stuettgen P, Cremer M, Goebel HH.
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
    Arikawa E, Hoffman EP, Kaido M, Nonaka I, Sugita H, Arahata K.
    Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
    Freund AA, Scola RH, Arndt RC, Lorenzoni PJ, Kay CK, Werneck LC.
    Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
    Ikeya K, Saito K, Yamauchi A, Kondo E, Komine S, Ikenaka H, Mishima M, Takahashi R, Harada T, Fukuyama Y.
    No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
    [Abstract] [Full Text] [Related]

  • 12. Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes.
    Norman A, Thomas N, Coakley J, Harper P.
    Lancet; 1989 Mar 04; 1(8636):466-8. PubMed ID: 2563842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
    Uchino M, Miike T, Iwashita H, Uyama E, Yoshioka K, Sugino S, Ando M.
    J Neurol Sci; 1994 Jul 04; 124(2):225-9. PubMed ID: 7964876
    [Abstract] [Full Text] [Related]

  • 16. Dystrophinopathies in females.
    Hausmanowa-Petrusewicz I, Fidziańska A, Niebrój-Dobosz I, Dorobek M, Bojakowski J.
    Folia Neuropathol; 2000 Jul 04; 38(1):7-12. PubMed ID: 11057028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A rare case of adult-onset Becker muscular dystrophy diagnosed by dystrophin staining].
    Ujike H, Tomita J, Kuroda S, Otsuki S, Arahata K.
    No To Shinkei; 1991 Oct 04; 43(10):975-9. PubMed ID: 1724729
    [Abstract] [Full Text] [Related]

  • 19. Dystrophin assay in muscular dystrophies: an Indian experience.
    Jain S, Sarkar C, Dinda AK, Maheshwari MC.
    Natl Med J India; 1993 Oct 04; 6(6):259-62. PubMed ID: 7950930
    [Abstract] [Full Text] [Related]

  • 20. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy.
    Maeda M, Nakao S, Miyazato H, Setoguchi M, Arima S, Higuchi I, Osame M, Taira A, Nomoto K, Toda H.
    Am Heart J; 1995 Apr 04; 129(4):702-7. PubMed ID: 7900621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.